Male sexual dysfunction and psychoactive drug use

References

• Laver MC. Sexual behaviour patterns in male hypertensives. Aust NZ J Med 1974: 4: 29·31
   PubMedGoogle Scholar
• Greenblatt DJ. Shader RI, Koch-Weser J. Psychotropic drug use In the Boston area. Arch Gen Psychiatry 1975: 32: 518–21
   PubMed Web of Science ®Google Scholar
• Prank E, Anderson C. Rubinstein D. Frequency of sexual dysfunction In “normal” couples. N Engl J Med 1978: 299: 111–5
   PubMed Web of Science ®Google Scholar
• Burnap DW, Golden JS. Sexual problems in medical practice. J Med Educ 1967: 42: 673–80
   PubMedGoogle Scholar
• Greenberg HR. Erectile impotence during the course of Tofranil therapy. Am J Psvchlatry 1965: 121:1021
   PubMed Web of Science ®Google Scholar
• Ruskin DB, Goldner RD. Treatment of depressions in private practice with imipramine. Dis Nerv Syst 1959: 20: 391–9
   Google Scholar
• Couper-Smaitt J, Rodham R. A technique for surveying side-effects of tricyelic drugs with reference to reported sexual effects. J Int Med Res 1973: 1: 473–6
   PubMedGoogle Scholar
• Simpson GM, Blair JH. Amuso D. Effects of antidepressants on genito-urinary function. Dis Nerv Syst 1965: 26: 787–9
   PubMedGoogle Scholar
• Clarke FC. The treatment of depression in general practice. S Afr Med J 1969: 43: 724–5
   PubMedGoogle Scholar
• Wyatt RJ. Pram DH, Buchbinder R, et al. Treatment of intractable narcolepsy with a monoamine oxidase inhibitor. N Engl J Med 1971: 285: 987–91
   PubMed Web of Science ®Google Scholar
• Vinařová E. Uhlir O, Stika L. et al. Side effects of lithium administration. Act Nerv Super (Praha) 1972: 14: 105–7
   PubMedGoogle Scholar
• Tennett G, Bancroft J, Cass J. The control of deviant sexual behavior by drugs: a double-blind controlled study of benperidol. chlorpromazine. and placebo. Arch Sex Behav 1974: 3: 261–71
   PubMed Web of Science ®Google Scholar
• Witton K. Sexual dysfunction secondary to Mellaril. Dis Nerv Syst 1962: 23: 175
   PubMedGoogle Scholar
• Haider I. Thioridazine and sexual dysfunctions. Int J Neuropsychiatry 1966: 2: 255–7
   PubMed Web of Science ®Google Scholar
• Kotin J, Wilbert DE, Verburg D, et al. Thioridazine and sexual dysfunction. Am J Psychiatry 1976: 133: 82–5
   PubMed Web of Science ®Google Scholar
• Dorman BW, Schmidt JD. Association of priapism In phenothiazine therapy. J Urol 1976: 116: 51–3
   PubMed Web of Science ®Google Scholar
• Bartholomew AA. A long-acting phenothiazine as a possible agent to control deviant sexual behavior. Am J Psychiatry 1968: 124: 917–22
   PubMed Web of Science ®Google Scholar
• Mills LC. Drug-induced Impotence. Am Fam Physician 1975: 12: 104–6
   PubMed Web of Science ®Google Scholar
• Story NL. Sexual dysfunction resulting from drug side effects. J Sex Res 1974: 10: 132–49
   PubMed Web of Science ®Google Scholar
• Usdin GL. Preliminary report on Librium, a new psychopharmacologic agent. J Lo Med Soc 1960: 112: 142–7
   Google Scholar
• Ansari JM. Impotence: prognosis (a controlled study). Br J Psychiatry 1976: 128: 194–8
   PubMed Web of Science ®Google Scholar
• Kohn RM. Nocturnal orthostatic syncope in pargyline therapy. JAMA 1964: 187: 229·30
   PubMed Web of Science ®Google Scholar
• Freyhan FA. Loss of ejaculation during Mellaril treatment. Am J Psychiatry 1961: 118: 171–2
   PubMed Web of Science ®Google Scholar
• Heller J. Another case of Inhibition of ejaculation as a side effect of Mellaril. Am J Psychiatry 1961: 118: 173
   PubMed Web of Science ®Google Scholar
• Datahlumty J. Mellaril: ejaculation disorders. Am J Psychiatry 1961: 118: 564
   Web of Science ®Google Scholar
• Tanbel DE. Mellaril: ejaculation disorders. Am J Psychiatry 1962: 119: 87
   Web of Science ®Google Scholar
• Clein L. Thioridazine and ejaculation. Br Med J 1962: 2: 548–9
   Google Scholar
• Greenberg HR. Carrillo C. Thioridazine Induced inhibition of masturbatory ejaculation in an adolescent. Am J Psychiatry 1968: 124: 991–3
   PubMed Web of Science ®Google Scholar
• Shader RI. Sexual dysfunction associated with thioridazine hydrochloride. JAMA 1964: 188: 1007–9
   PubMed Web of Science ®Google Scholar
• Shader RI. Ejaculation disorders. In: Shader RI. DiMascto A. eds. Psychotropic drug side effects: clinical and theoretical perspectives. Baltimore: Williams & Wilkins. 1970
   Google Scholar
• Girgis SM. Etriby A. El-Hefnawy H. et al. Aspermia: a survey of 49 cases. Fertil Steril 1968: 19: 580–8
   PubMed Web of Science ®Google Scholar
• Shader RI, Grinspoon L. Schizophrenia oligospermia. and the phenothiazines. Dis Nerv Syst 1967: 28: 240–4
   PubMedGoogle Scholar
• Mellgren A. Treatment of ejaculation praecox with thioridazine. Psychother Psychosom 1967: 15: 454–60
   Web of Science ®Google Scholar
• Singh H. Therapeutic use of thioridazine in premature ejaculation. Am J Psychiatry 1963: 119: 891
   PubMed Web of Science ®Google Scholar
• Shader RI. Sexual dysfunction associated with mesoridazine besylate (Serentil). Psychopharmacol Bull 1972: 27: 293–4
   Google Scholar
• Ditman KS. Inhibition of ejaculation by chlorprothixene. Am J Psychiatry 1964: 120: 1004–5
   PubMed Web of Science ®Google Scholar
• Blair JH. Simpson GM. Effect of antipsychotic drugs on reproductive functions. Dis Nerv Syst 1966: 27: 45–7
   Google Scholar
• Singh H. A case of Inhibition of ejaculation as a side effect of Mellaril. Am J Psychiatry 1961: 117: 1041–2
   Web of Science ®Google Scholar
• Baumgerten HG, Onus C, Sjoberg NO. Neural mechanisms in male fertility. In: Selarra JJ. Markland C. Speldel JJ. eds. Control of male fertility. New York. Harper & Row. 1975
   Google Scholar
• Kedia K, Markland C. Effects of sympathectomy and drugs on ejaculation. In: Sciarra et al. eds
   Google Scholar
• Hughes JM. Failure to ejaculate with chlordiazepoxide. Am J Psychiatry 1964: 121: 610–1
   PubMed Web of Science ®Google Scholar
• Weiss HD. The physiology of human penile erection. Ann Intern Med 1972:76:793–9
   PubMed Web of Science ®Google Scholar
• Bors E. Comarr AE. Neurological disturbances of sexual function with special reference to 529 patients with spinal cord Injury. Urol Surv 1960: 10: 191–222
   Google Scholar
• Bernstein JG. Chemotherapy in psychiatry. In: Hackett TP. Cassem NH. eds. Massachusetts General Hospital handbook of general hospital psychiatry. St Louis. CV Mosby. 1978: 451–82
   Google Scholar
• Snyder S, Greenberg D, Yamamura HI. Antischlzophrenic drugs and brain cholinergic receptors. Arch Gen Psychiatry 1974: 31: 58–61
   PubMed Web of Science ®Google Scholar
• MacClean PD. Brain mechanisms of primal sexual functions and related behavior. In: Sandler M. Gessa GL. eds. Sexual behavior pharmacology and biochemistry. New York. Raven Press. 1975
   Google Scholar
• Hierons R, Saunders M. Impotence in patients with temporal-lobe lesions. Lancet 1966: 2: 761–3
   PubMed Web of Science ®Google Scholar
• Gessa GL. Tagliamonte A. Possible role of brain serotonin and dopamine in controlling male sexual behavior. Adv Biochem Psychopharmacol 1974: 11: 217–28
   PubMedGoogle Scholar
• Baldessarini RJ. The use of chemotherapy In outpatient psychiatry. In: Lazare A. ed. Outpatient psychiatry: diagnosis and treatment. Baltimore: Williams & Wilkins. 1979: 563–95
   Google Scholar
• Kleeman FJ. The physiology of the internal urinary sphincter. J Urol 1970: 104: 549–54
   PubMed Web of Science ®Google Scholar
• Bernstein JG. Medical-psychiatric dnig interactions. In: Hackett and Cassem. eds. pp 483–507
   Google Scholar
• Gruen PG. Sachar EJ, Altman N. et al. Relation of plasma prolactin to clinical response In schizophrenic patients. Arch Gen Psychiatry 1978: 35: 1222–7
   PubMed Web of Science ®Google Scholar
• Beumont PJ, Corker CS. Friesen HC, et al. The effects of phenothiazines on endocrine function. 11. Effects In men and postmenopausal women. Br J Psychiatry 1974: 124: 420–30
   PubMed Web of Science ®Google Scholar
• Siria SG. Siris ES. Van Kammem DP, et al. Effects of dopamine blockade on gonadotropins and testosterone in men. Am J Psychiatry 1980: 137: 211–4
   PubMed Web of Science ®Google Scholar